Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02889211 · ClinicalTrials.gov registry record · NA
Brain Function in Depression and Insulin Resistance
A NA study, sponsored by University of Pittsburgh.
- Terminated
- Registry status
- NA
- Development phase
- 42
- Enrollment target
NCT02889211 is a NA study that was terminated before completion, run by University of Pittsburgh. The registered enrollment target is 42 participants.
The verdict
NCT02889211, a NA study, was terminated before completion, sponsored by University of Pittsburgh.
- TERMINATED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
Study Summary
The purpose of this study is to help researchers learn about how the brain responds to rewards. This study is interested in seeing how these responses differ between people who are more and less responsive to insulin in their body, and people with and without depression.
Interventions
- BEHAVIORAL Gambling Task
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2016-08 |
| Est. Completion | 2017-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02889211
The ClinicalTrials.gov registry entry for NCT02889211 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Gambling Task is the first listed.
NCT02889211 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02889211 about?
NCT02889211 is a clinical study titled "Brain Function in Depression and Insulin Resistance". The purpose of this study is to help researchers learn about how the brain responds to rewards. This study is interested in seeing how these responses differ between people who are more and less responsive to insulin in their body, and people with and without depression.
What is the current status of trial NCT02889211?
This trial is currently terminated. It is a NA study. The enrollment target is 42 participants. The study started on 2016-08. Estimated completion is 2017-12.
What interventions are being tested in trial NCT02889211?
The interventions under investigation include: Gambling Task (BEHAVIORAL).
Who is sponsoring clinical trial NCT02889211?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.